series-c-plus
Stage
2
Investors
About
Prolacta develops and supplies pharmaceutical-grade human milk-based nutritional products primarily designed to improve health outcomes in premature and critically ill infants.
Explore Prolacta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.